We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
631
Increased
3,220
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMRT icon
3826
SmartRent
SMRT
$286M
$23K ﹤0.01%
10,317
+7,158
+227% +$28.2K
TNYA icon
3827
Tenaya Therapeutics
TNYA
$163M
$23K ﹤0.01%
7,942
+5,200
+190% +$24.3K
TRML
3828
DELISTED
Tourmaline Bio
TRML
$23K ﹤0.01%
864
+527
+156% +$19.2K
UTMD icon
3829
Utah Medical Products
UTMD
$226M
$23K ﹤0.01%
273
+66
+32% +$5.83K
YMAB
3830
DELISTED
Y-mAbs Therapeutics
YMAB
$23K ﹤0.01%
1,584
-2,600
-62% -$43.1K
MSPR
3831
DELISTED
MSP Recovery Inc
MSPR
$23K ﹤0.01%
+4
New +$28.5K
KLRS
3832
Kalaris Therapeutics
KLRS
$97.1M
$23K ﹤0.01%
129
-157
-55% -$24.5K
CNSL
3833
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$23K ﹤0.01%
5,619
+3,582
+176% +$22.2K
LUMO
3834
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$23K ﹤0.01%
2,582
-698
-21% -$5.8K
EXAI
3835
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$23K ﹤0.01%
2,851
+906
+47% +$9.14K
CBD
3836
DELISTED
Companhia Brasileira de Distribuicao
CBD
$23K ﹤0.01%
6,550
+5,510
+530% +$19.5K
CBAY
3837
DELISTED
Cymabay Therapeutics
CBAY
$23K ﹤0.01%
6,527
-5,859
-47% -$21K
FAZE
3838
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$23K ﹤0.01%
2,334
-632
-21% -$8.39K
MDWT
3839
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$23K ﹤0.01%
1,681
+1,635
+3,554% +$22.4K
CORR
3840
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$23K ﹤0.01%
14,399
-8,677
-38% -$19.6K
NOVN
3841
DELISTED
Novan, Inc. Common Stock
NOVN
$23K ﹤0.01%
12,520
+11,311
+936% +$28.5K
IGAC
3842
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
$23K ﹤0.01%
2,267
+62
+3% +$618
AVEO
3843
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$23K ﹤0.01%
2,739
+2,106
+333% +$16.2K
PFSW
3844
DELISTED
PFSweb, Inc.
PFSW
$23K ﹤0.01%
2,462
+256
+12% +$2.64K
AAME icon
3845
Atlantic American Corp
AAME
$29.6M
$22K ﹤0.01%
7,935
+4,167
+111% +$12.3K
ADV icon
3846
Advantage Solutions
ADV
$420M
$22K ﹤0.01%
420
-68
-14% -$6.27K
ADVM
3847
DELISTED
Adverum Biotechnologies
ADVM
$22K ﹤0.01%
2,387
+1,593
+201% +$20.9K
ALCO icon
3848
Alico
ALCO
$297M
$22K ﹤0.01%
809
-9,445
-92% -$319K
ANTX icon
3849
AN2 Therapeutics
ANTX
$226M
$22K ﹤0.01%
1,279
-3,083
-71% -$35.9K
ATNI icon
3850
ATN International
ATNI
$488M
$22K ﹤0.01%
580
-43
-7% -$1.95K
152 153
154
155 156

Similar funds

AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $4.06B AUM 24.91% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 44.45% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $4.11B AUM 27.59% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 631 new positions and adding to 3,220 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 631 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.